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Objective: To determine whether there is an association between the proﬁle of cognitive dys-
function and academic outcomes in patients with juvenile systemic lupus erythematosus
(JSLE).
Methods: Patients aged ≤18 years at the onset of the disease and education level at or above
the ﬁfth grade of elementary school were selected. Cognitive evaluation was performed
according to the American College of Rheumatology (ACR) recommendations. Symptoms
of  anxiety and depression were assessed by Beck scales; disease activity was assessed by
Systemic Lupus Erythematosus Disease Activity Index (SLEDAI); and cumulative damage
was  assessed by Systemic Lupus International Collaborating Clinics (SLICC). The presence
of  autoantibodies and medication use were also assessed. A signiﬁcance level of 5% (p < 0.05)
was  adopted.
Results: 41 patients with a mean age of 14.5 ± 2.84 years were included. Cognitive dysfunction
was noted in 17 (41.46%) patients. There was a signiﬁcant worsening in mathematical perfor-
mance in patients with cognitive dysfunction (p = 0.039). Anxiety symptoms were observed
in  8 patients (19.51%) and were associated with visual perception (p = 0.037) and symptoms
of  depression were observed in 1 patient (2.43%).
Conclusion: Patients with JSLE concomitantly with cognitive dysfunction showed worse aca-n mathematics compared to patients without cognitive impairment.demic performance i©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Associac¸ão  entre  desempenho  acadêmico  e  disfunc¸ão  cognitiva
em  pacientes  com  lúpus  eritematoso  sistêmico  juvenil
Palavras-chave:
Lúpus eritematoso sistêmico
juvenil
Disfunc¸ão  cognitiva
Desempenho acadêmico
r  e  s  u  m  o
Objetivo: Determinar se há associac¸ão entre o perﬁl de disfunc¸ão cognitiva e os resultados
acadêmicos em pacientes com lúpus eritematoso sistêmico juvenil (LESj).
Métodos: Foram selecionados pacientes com idade de início da doenc¸a ≤ 18 anos e com
escolaridade mínima do quinto ano do Ensino Fundamental seguidos em um hospital
universitário. A avaliac¸ão cognitiva foi feita de acordo com as recomendac¸ões do Colégio
Americano de Reumatologia (ACR). Os sintomas de ansiedade e depressão foram avaliados
pelas  escalas Beck, a atividade da doenc¸a foi avaliada pelo Systemic Lupus Erythematosus
Disease Activity Index (Sledai) e o dano cumulativo pelo Systemic Lupus International Col-
laborating Clinics (Slicc). Também foram avaliados a presenc¸a de autoanticorpos e o uso de
medicac¸ão.  Adotou-se nível de signiﬁcância de 5% (p < 0,05).
Resultados: Foram incluídos 41 pacientes com média de 14,5 ± 2,84 anos. Disfunc¸ão cog-
nitiva foi observada em 17 (41,46%). Observou-se pioria signiﬁcativa no desempenho de
matemática em pacientes com disfunc¸ão cognitiva (p = 0,039). Sintomas de ansiedade foram
observados em oito pacientes (19,51%) e estavam associados à percepc¸ão visual (p = 0,037) e
sintomas de depressão foram observados em um paciente (2,43%).
Conclusão: Pacientes com LESj com disfunc¸ão cognitiva apresentam pior desempenho
acadêmico em matemática em relac¸ão a pacientes sem disfunc¸ão cognitiva.
©  2016 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC
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tntroduction
ystemic lupus erythematosus (SLE) is a chronic and autoim-
une inﬂammatory disease of connective tissue. Of unknown
tiology, SLE is linked to genetic, hormonal, environmental
actors, and to the use of some medications. This disease
ostly affects women in childbearing age, especially between
5 and 50 years. However, approximately 20% of patients are
ffected during childhood or adolescence (JSLE), being pre-
ominantly of female gender.1–3
JSLE patients show a more  severe form of the disease
nd develop neuropsychiatric symptoms at higher frequen-
ies than in adult patients.4 Cognitive disorders are common
nd affect mainly attention, concentration, learning, memory,
nformation processing and executive functions, even in the
pparent absence of disease activity or of other neuropsychi-
tric events.5–8
Few studies available in the literature suggest that JSLE
atients are at risk of poor academic performance,9,10 espe-
ially causing difﬁculties in arithmetic learning, reading
omprehension, visual memory  and inability to solve com-
lex problems.10 For these reasons, patients with SLE can meet
ewer educational milestones, for example, not ﬁnishing high
chool or college graduation – factors associated with a lower
robability of employment and of success at work.10–12 In this
cenario, the aim of this study was to determine whether there
s an association between the proﬁle of cognitive dysfunction
nd academic outcomes in patients with JSLE.
aterials  and  methodsonsecutive patients with JSLE seen at the Pediatric Rheuma-
ology Outpatient Clinic, Hospital das Clínicas, UniversidadeBY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Estadual de Campinas (UNICAMP), whose clinical and lab-
oratory manifestations were routinely studied according to
an already established protocol, were selected.13,14 Inclusion
criteria were: patients with age of onset of disease ≤18,15 and
with ﬁfth grade of elementary school as the minimum level of
scholarship. The study was approved by the Research Ethics
Committee (CEP No. 920/2007) of UNICAMP and all the partic-
ipants and legal guardians signed an informed consent form
(FICF).
Cognitive assessment was performed by a qualiﬁed
psychologist through the application of a survey battery
lasting about two hours, consisting of tests adapted to
the juvenile population and validated for the Portuguese
language and selected from the battery recommended by
the American College of Rheumatology (ACR).16 The fol-
lowing tests for evaluation of cognitive functions were
selected:
• Picture Arrangement Test: evaluates temporal
reasoning17,18
• Code Test: evaluates processing speed17,18
• Picture Completion Test: evaluates visual perception17,18
• Cube Test: evaluates spatial reasoning17,18
• Digit Test: assesses immediate and working memory17,18
• Vocabulary Test: evaluates semantic memory,  educational
background and general intelligence17,18
• Rey Complex Figure Test: evaluates perceptual organization,
planning, praxis and memory19
• Boston Naming Test: evaluates visual recognition and nam-
ing capacity20
• FAZ Verbal Fluency Test: assesses verbal-phonological
ﬂuency21• Trail Making Test: assesses visual tracking, sustained atten-
tion and motor dexterity22
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Table 1 – Demographic, clinical and immunological data
of juvenile systemic lupus erythematosus patients with
and without cognitive impairment.
Variables Patients with
cognitive
dysfunction
n = 17
Patients
without
cognitive
dysfunction
n  = 24
p-Value
Female 17 (100%) 21 (87.5%) 0.128
Age at
diagnosis
(mean/SD)
11.47 years
(2.47)
13.37 years
(3.53)
0.038a
Disease
duration
(mean/SD)
5.11  years (4.21) 7.58 years (4.93) 0.102
Active
disease
5 patients
(29.41%)
6  patients
(28.57%)
0.756
Cumulative
damage
3 patients
(17.64%)
5  patients
(20.83%)
0.75
Anxiety 5 patients
(29.41%)
3  patients
(12.5%)
0.241
Depression 1 patient
(5.88%)
0  patient (0%) 0.235
Anti-P 5 patients
(29.41%)
3  patients
(12.5%)
0.589
ANA 17 patients
(100%)
18  patients
(75%)
0.033a
Anti-DNA 10 patients
(58.82%)
16  patients
(66.66%)
0.745
Anti-Smith 7 patients
(41.17%)
7  patients
(29.17%)
0.430
Anticardiolipin 6 patients
(35.29%)
5  patients
(20.83%)
0.476
Lupus antico-
agulant
6  patients
(35.29%)
13  patients
(54.16%)
0.342254  r e v b r a s r e u m a t
• Stroop Neuropsychological Screening Test: evaluates selec-
tive attention, inhibitory control and mental ﬂexibility23
Each patient had his/her scores counted individually.
Seventy-one controls matched for gender, age and socio-
economic status were included in order to obtain normative
data of applied tests. Presence of cognitive impairment has
been deﬁned in cases of cognitive function with a mean Z-
score ≤−2 SD or two or more  functions with a mean Z-score
between −1 and −2 SD.24
On the day of the cognitive tests, the school report of the
last academic semester of each participant was requested. The
participants were grouped by discipline: Portuguese/English/
Spanish; Geography/History; Physical/Chemical/Biological
Sciences; Mathematics; Physical Education; Arts; and Soci-
ology/Philosophy. School grades ≥7 (70% success) were
considered as satisfactory.24–28
Disease activity was assessed by the Systemic Lupus Ery-
thematosus Disease Activity Index (SLEDAI) questionnaire and
the disease was considered active if the sum of SLEDAI points
was >3.29 Cumulative damage was assessed by the application
of a questionnaire speciﬁcally developed for this purpose, the
Systemic Lupus International Collaborating Clinics/American
College of Rheumatology Damage Index (SDI) (SLICC/ACR-
DI).30
To assess the presence of depressive symptoms, the Chil-
dren’s Depression Inventory – CDI31 for subjects between 7
and 17 years32 was applied; this tool is an adaptation of
the BDI (Beck Depression Inventory). Anxiety symptoms were
assessed using the Beck Anxiety Inventory – BAI.33,34
Lab work-up of autoantibodies was carried out; routine
techniques used in the Clinical Pathology Laboratory and in
the Allergy and Immunology Research Laboratory at Hospi-
tal das Clínicas, UNICAMP were used. Antinuclear antibody
(ANA) (by indirect immunoﬂuorescence; positive if title >1:40);
anti-DNA antibody (by indirect immunoﬂuorescence with
Crithidia luciliae as substrate)35; anti-Smith antibody (by dou-
ble immunodiffusion); anticardiolipin antibody (by enzyme
immunoassay); and lupus anticoagulant (by TTPA and Rus-
sell method) were determined.36 Anti-ribosomal P protein
antibody (anti-P) was measured by Enzyme Linked Immuno
Sorbent Assay (ELISA).
Medications prescribed on the date of the cognitive tests
were taken into account in this study. The drugs were
corticosteroids, anti-malarials (chloroquine and hydroxy-
chloroquine), and other immunosuppressive drugs (azathio-
prine, cyclophosphamide, cyclosporine, methotrexate and
mycophenolate mofetil).
Statistical analysis was performed using the Statistical and
Graphical Software (Systat) program. Shapiro–Wilk normality
test was applied for obtaining results. For statistical anal-
ysis, nonparametric Kruskal–Wallis and Fisher’s exact test
were performed. The signiﬁcance level was set at 5%, i.e.,
p < 0.05.Results
Forty-one patients with JSLE (mean age, 14.5 ± 2.84 years), of
whom 38 (92.68%) were females, were included and assesseda p < 0.05.
for cognitive impairment and academic notes. Twenty-three
(56.09%) patients were elementary education level students,
three (7.31%) had completed elementary school and did not
continue their studies, and 15 (36.58%) were high school stu-
dents. The mean age of onset of the disease was 12.58 ± 3.24
years; and the disease duration, until the time of testing, was
2.4 ± 2.63 years. Eleven (26.82%) patients had active disease at
the time of testing (mean of SLEDAI, 7.27 ± 2.62).
The control group was composed of 71 healthy volunteers
(90.14% women) with mean age of 16.37 ± 5.21 years. No sta-
tistically signiﬁcant differences were found between patients
and controls regarding gender and age, and socioeconomic
status. According to the criteria adopted for the deﬁnition
of cognitive dysfunction, 17 (41.46%) patients and 26 (36.6%)
controls had cognitive impairment (p = 0.08).
JSLE patients were divided into two subgroups according
to the presence or absence of cognitive dysfunction. It was
observed that the presence of cognitive impairment was asso-
ciated with younger age at diagnosis of JSLE (p = 0.038) and an
association between cognitive impairment and ANA (p = 0.033)
was noted. Demographic, clinical and immunological data are
listed in Table 1.Symptoms of anxiety were observed in 8 patients (19.51%)
and were associated with visual perception (p = 0.037), but
there was no association of these symptoms with presence
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Table 2 – School grades between patients with juvenile
systemic lupus erythematosus with and without
cognitive impairment.
Discipline Patients with
cognitive
dysfunction
(mean ± SD)
Patients
without
cognitive
dysfunction
(mean ± SD)
p-Value
Portuguese/
English/Spanish
7.09  ± 1.29 6.93 ± 1.08 0.302
Geography/History 7.12 ± 1.51 7.38 ± 1.54 0.791
Sciences 6.26 ± 1.52 7.04 ± 1.98 0.195
Physical
Education
7.55 ± 1.67 8.04 ± 1.92 0.604
Mathematics 6.68 ± 2.06 7.37 ± 1.65 0.039a
Arts 8.14 ± 1.59 8.26 ± 0.98 0.662
Sociology/Philosophy 7.62 ± 1.05 7.14 ± 1.27 0.504
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f cognitive impairment (p = 0.988). Symptoms of depression
ere observed in 1 (2.43%) patient and again there was no
ssociation with cognitive impairment (p = 1.0). No association
as observed between symptoms of anxiety and depression,
hen compared with academic grades.
No association of cognitive impairment with any medica-
ion (corticosteroids, p = 0.988; immunosuppressants, p = 0.75
nd antimalarials, p = 0.988) was observed.
When comparing patients with versus without cognitive
mpairment, school performance showed signiﬁcant differ-
nce between groups only for math grades (p = 0.039) (Table 2).
iscussion
n our sample, the frequency of cognitive dysfunction was
1.46%; this ﬁnding was consistent with other studies reported
n the literature.4,6,8,24
The presence of cognitive impairment was associated with
oorer performance in mathematics in our patients. Another
tudy found that children with JSLE had poorer academic
esults versus individuals without this disease.9 It is sug-
ested that deﬁcits in language ability are among the ﬁrst
arkers of presence of neurological disorder in patients
ith JSLE, and that this difﬁculty may be present even in
atients without neuropsychiatric manifestations.6 In this
tudy, there was no signiﬁcant difference in language-related
isciplines.
It is a very difﬁcult task to deﬁne school performance,
n the face of the multiple variables used to assess this
henomenon.25 Unsatisfactory performance was deﬁned by
cCall as the performance of an individual who does not nec-
ssarily obtain low grades, but whose grades are below his/her
xpectations.26 There is greater consensus in considering as
nsatisfactory a performance substantially below expecta-
ions for the student’s own cognitive ability.25,26
It is also difﬁcult to assess school performance, since this
arameter depends on different factors, among which are:
chool physical characteristics, teacher qualiﬁcations, educa-
ion level of parents, and education level of the student.28 In
he literature, several measures are available for evaluation of 6;5 6(3):252–257 255
school performance, including: grade repetition, suspension,
grades lower than the expected for the student’s coefﬁcient of
intelligence, and low grades.37 In our study, in the deﬁnition
of poor school performance we considered the occurrence of
unsatisfactory notes, i.e. educational achievement <70% for a
certain class content.25–28
It is known that cognitive dysfunction is associated with
high morbidity in patients with JSLE.5,12 However, a major
obstacle to understanding the neuropsychological function-
ing of these patients is the lack of a standardized criterion for
the identiﬁcation of this dysfunction.8,24
The cognitive impairment evaluation consisted of tools
adapted to juvenile age group and selected from the battery
suggested by ACR16 for evaluation of cognitive dysfunction
in adults, and also with batteries used in recent studies in
patients with JSLE.4,6,8,9,24
In this study, we found no evidence that disease activity
plays a role in cognitive function. This ﬁnding is supported
by two recently published pediatric studies, in which the
authors found no association between disease activity and
cognitive dysfunction.4,8 On the other hand, when individuals
with more  severe conditions, e.g., hospitalized patients, were
included, we could observe an association between disease
activity and cognitive dysfunction.12
Other authors found no association between cognitive
deﬁcit and cumulative damage38 or medication,39 which was
conﬁrmed in our study.
In children, reports of an association of autoantibodies with
cognitive impairment are sparse and inconclusive; moreover,
such studies also did not identify in their sample a direct
association between the presence of antibodies and cognitive
dysfunction.4,8 However, in our study we found an association
with ANA and cognitive impairment, suggesting that there is
a link between autoimmunity and cognitive functioning.
It is known that living with a chronic disease can cause
major adaptive problems associated with emotional distress,
such as irritability, insomnia, loss of appetite, emotional insta-
bility, and changes in memory  and concentration, which may
be reﬂected in school performance.27,28,40 For this reason,
some authors point out behavior difﬁculties as a risk factor
for poor academic performance of individuals with JSLE.8,11,41
Behavior difﬁculties, although being a variable not evaluated
in this study, are important in patients with chronic disease,
especially in adolescents; these factors may have had some
bearing on the results.
Although cognitive disorder frequency has been compared
against healthy individuals, unfortunately we did not compute
the academic performance of these controls for comparison.
In conclusion, patients suffering from JSLE and with cog-
nitive impairment exhibit a worse academic performance in
math, compared to JSLE patients without cognitive impair-
ment.
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